• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2023

    9/21/23 11:00:33 AM ET
    $ADC
    $ALVO
    $BHF
    $BNL
    Real Estate Investment Trusts
    Real Estate
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ADC alert in real time by email

    Upgrades

    According to Truist Securities, the prior rating for International Paper Co (NYSE:IP) was changed from Hold to Buy. In the second quarter, International Paper showed an EPS of $0.59, compared to $1.24 from the year-ago quarter. The current stock performance of International Paper shows a 52-week-high of $41.89 and a 52-week-low of $29.00. Moreover, at the end of the last trading period, the closing price was at $33.72.

    According to B of A Securities, the prior rating for Nutanix Inc (NASDAQ:NTNX) was changed from Neutral to Buy. Nutanix earned $0.24 in the fourth quarter, compared to $0.17 in the year-ago quarter. The stock has a 52-week-high of $36.71 and a 52-week-low of $19.97. At the end of the last trading period, Nutanix closed at $33.75.

    For Enphase Energy Inc (NASDAQ:ENPH), Seaport Global upgraded the previous rating of Neutral to Buy. For the second quarter, Enphase Energy had an EPS of $1.47, compared to year-ago quarter EPS of $1.07. The stock has a 52-week-high of $339.88 and a 52-week-low of $116.86. At the end of the last trading period, Enphase Energy closed at $123.97.

    For European Wax Center Inc (NASDAQ:EWCZ), Piper Sandler upgraded the previous rating of Neutral to Overweight. European Wax Center earned $0.11 in the second quarter, compared to $0.19 in the year-ago quarter. The stock has a 52-week-high of $20.70 and a 52-week-low of $12.02. At the end of the last trading period, European Wax Center closed at $17.24.

    Baird upgraded the previous rating for HealthEquity Inc (NASDAQ:HQY) from Neutral to Outperform. HealthEquity earned $0.53 in the second quarter, compared to $0.33 in the year-ago quarter. At the moment, the stock has a 52-week-high of $79.16 and a 52-week-low of $48.86. HealthEquity closed at $70.97 at the end of the last trading period.

    According to JP Morgan, the prior rating for New Jersey Resources Corp (NYSE:NJR) was changed from Underweight to Neutral. New Jersey Resources earned $0.10 in the third quarter, compared to $0.04 in the year-ago quarter. The stock has a 52-week-high of $55.84 and a 52-week-low of $38.23. At the end of the last trading period, New Jersey Resources closed at $42.17.

    For Five9 Inc (NASDAQ:FIVN), Deutsche Bank upgraded the previous rating of Hold to Buy. For the second quarter, Five9 had an EPS of $0.52, compared to year-ago quarter EPS of $0.34. The current stock performance of Five9 shows a 52-week-high of $89.58 and a 52-week-low of $46.63. Moreover, at the end of the last trading period, the closing price was at $66.42.

    According to Morgan Stanley, the prior rating for Buenaventura Mining Co Inc (NYSE:BVN) was changed from Equal-Weight to Overweight. Buenaventura Mining Co earned $0.03 in the second quarter, compared to $0.16 in the year-ago quarter. The current stock performance of Buenaventura Mining Co shows a 52-week-high of $8.92 and a 52-week-low of $5.75. Moreover, at the end of the last trading period, the closing price was at $8.26.

    According to Keefe, Bruyette & Woods, the prior rating for Truist Financial Corp (NYSE:TFC) was changed from Market Perform to Outperform. Truist Finl earned $0.95 in the second quarter, compared to $1.20 in the year-ago quarter. The current stock performance of Truist Finl shows a 52-week-high of $53.34 and a 52-week-low of $25.56. Moreover, at the end of the last trading period, the closing price was at $28.37.

    See all analyst ratings upgrades.

    Downgrades

    According to William Blair, the prior rating for Splunk Inc (NASDAQ:SPLK) was changed from Outperform to Market Perform. Splunk earned $0.71 in the second quarter, compared to $0.09 in the year-ago quarter. The current stock performance of Splunk shows a 52-week-high of $125.91 and a 52-week-low of $65.00. Moreover, at the end of the last trading period, the closing price was at $119.59.

    For Seelos Therapeutics Inc (NASDAQ:SEEL), Guggenheim downgraded the previous rating of Buy to Neutral. In the second quarter, Seelos Therapeutics showed an EPS of $0.22, compared to $0.20 from the year-ago quarter. The current stock performance of Seelos Therapeutics shows a 52-week-high of $1.66 and a 52-week-low of $0.23. Moreover, at the end of the last trading period, the closing price was at $0.31.

    According to Argus Research, the prior rating for Silk Road Medical Inc (NASDAQ:SILK) was changed from Buy to Hold. Silk Road Medical earned $0.35 in the second quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $58.04 and a 52-week-low of $15.94. At the end of the last trading period, Silk Road Medical closed at $15.98.

    Citigroup downgraded the previous rating for Frontier Group Holdings Inc (NASDAQ:ULCC) from Buy to Neutral. Frontier Group Holdings earned $0.31 in the second quarter, compared to $0.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.34 and a 52-week-low of $4.78. Frontier Group Holdings closed at $4.80 at the end of the last trading period.

    For Brighthouse Financial Inc (NASDAQ:BHF), Goldman Sachs downgraded the previous rating of Neutral to Sell. Brighthouse Finl earned $4.13 in the second quarter, compared to $3.29 in the year-ago quarter. At the moment, the stock has a 52-week-high of $60.54 and a 52-week-low of $39.23. Brighthouse Finl closed at $51.27 at the end of the last trading period.

    According to Cantor Fitzgerald, the prior rating for Seelos Therapeutics Inc (NASDAQ:SEEL) was changed from Overweight to Neutral. In the second quarter, Seelos Therapeutics showed an EPS of $0.22, compared to $0.20 from the year-ago quarter. The current stock performance of Seelos Therapeutics shows a 52-week-high of $1.66 and a 52-week-low of $0.23. Moreover, at the end of the last trading period, the closing price was at $0.31.

    Goldman Sachs downgraded the previous rating for BanColombia SA (NYSE:CIB) from Buy to Neutral. For the second quarter, BanColombia had an EPS of $1.37, compared to year-ago quarter EPS of $1.78. The current stock performance of BanColombia shows a 52-week-high of $30.89 and a 52-week-low of $21.55. Moreover, at the end of the last trading period, the closing price was at $28.10.

    See all analyst ratings downgrades.

    Initiations

    B. Riley Securities initiated coverage on YETI Holdings Inc (NYSE:YETI) with a Neutral rating. The price target for YETI Holdings is set to $50.00. In the second quarter, YETI Holdings showed an EPS of $0.57, compared to $0.63 from the year-ago quarter. At the moment, the stock has a 52-week-high of $51.27 and a 52-week-low of $27.95. YETI Holdings closed at $49.55 at the end of the last trading period.

    BTIG initiated coverage on Overstock.com Inc (NASDAQ:OSTK) with a Neutral rating. Overstock.com earned $0.02 in the second quarter, compared to $0.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.27 and a 52-week-low of $17.05. Overstock.com closed at $17.95 at the end of the last trading period.

    With an Underperform rating, Jefferies initiated coverage on Ecopetrol SA (NYSE:EC). The price target seems to have been set at $11.20 for Ecopetrol. Ecopetrol earned $0.45 in the second quarter, compared to $1.30 in the year-ago quarter. The current stock performance of Ecopetrol shows a 52-week-high of $13.08 and a 52-week-low of $8.59. Moreover, at the end of the last trading period, the closing price was at $12.90.

    With a Hold rating, Jefferies initiated coverage on YPF SA (NYSE:YPF). The price target seems to have been set at $14.50 for YPF. YPF earned $0.82 in the second quarter, compared to $2.01 in the year-ago quarter. The current stock performance of YPF shows a 52-week-high of $16.19 and a 52-week-low of $6.01. Moreover, at the end of the last trading period, the closing price was at $12.79.

    Jefferies initiated coverage on Pampa Energia SA (NYSE:PAM) with a Buy rating. The price target for Pampa Energia is set to $56.00. For the second quarter, Pampa Energia had an EPS of $3.01, compared to year-ago quarter EPS of $1.20. The stock has a 52-week-high of $48.79 and a 52-week-low of $22.05. At the end of the last trading period, Pampa Energia closed at $40.33.

    With a Buy rating, Jefferies initiated coverage on GeoPark Ltd (NYSE:GPRK). The price target seems to have been set at $14.50 for GeoPark. GeoPark earned $0.59 in the second quarter, compared to $1.13 in the year-ago quarter. The current stock performance of GeoPark shows a 52-week-high of $16.17 and a 52-week-low of $8.83. Moreover, at the end of the last trading period, the closing price was at $10.11.

    Jefferies initiated coverage on Petroleo Brasileiro SA Petrobras (NYSE:PBR) with a Buy rating. The price target for Petrobras Brasileiro is set to $21.20. Petrobras Brasileiro earned $0.90 in the second quarter, compared to $1.68 in the year-ago quarter. The current stock performance of Petrobras Brasileiro shows a 52-week-high of $16.32 and a 52-week-low of $8.88. Moreover, at the end of the last trading period, the closing price was at $15.33.

    Jefferies initiated coverage on Ultrapar Participacoes SA (NYSE:UGP) with an Underperform rating. The price target for Ultrapar Participacoes is set to $3.30. In the second quarter, Ultrapar Participacoes showed an EPS of $0.04, compared to $0.07 from the year-ago quarter. The current stock performance of Ultrapar Participacoes shows a 52-week-high of $4.11 and a 52-week-low of $2.13. Moreover, at the end of the last trading period, the closing price was at $3.86.

    Jefferies initiated coverage on Vista Energy SAB de CV (NYSE:VIST) with a Buy rating. The price target for Vista Energy is set to $40.00. For the second quarter, Vista Energy had an EPS of $0.52, compared to year-ago quarter EPS of $1.06. At the moment, the stock has a 52-week-high of $28.37 and a 52-week-low of $8.37. Vista Energy closed at $27.00 at the end of the last trading period.

    Barclays initiated coverage on Organon & Co (NYSE:OGN) with an Overweight rating. The price target for Organon is set to $28.00. For the second quarter, Organon had an EPS of $1.31, compared to year-ago quarter EPS of $1.25. At the moment, the stock has a 52-week-high of $32.43 and a 52-week-low of $18.87. Organon closed at $18.92 at the end of the last trading period.

    Barclays initiated coverage on Alvotech (NASDAQ:ALVO) with a Equal-Weight rating. The price target for Alvotech is set to $10.00. At the moment, the stock has a 52-week-high of $14.60 and a 52-week-low of $5.56. Alvotech closed at $9.10 at the end of the last trading period.

    For Broadstone Net Lease Inc (NYSE:BNL), JMP Securities initiated coverage, by setting the current rating at Market Perform. In the second quarter, Broadstone Net Lease showed an EPS of $0.35, compared to $0.35 from the year-ago quarter. The current stock performance of Broadstone Net Lease shows a 52-week-high of $18.86 and a 52-week-low of $14.99. Moreover, at the end of the last trading period, the closing price was at $15.97.

    Wells Fargo initiated coverage on Realty Income Corp (NYSE:O) with a Equal-Weight rating. The price target for Realty Income is set to $59.00. For the second quarter, Realty Income had an EPS of $1.00, compared to year-ago quarter EPS of $0.97. The current stock performance of Realty Income shows a 52-week-high of $68.85 and a 52-week-low of $53.65. Moreover, at the end of the last trading period, the closing price was at $53.80.

    Wells Fargo initiated coverage on Agree Realty Corp (NYSE:ADC) with an Overweight rating. The price target for Agree Realty is set to $70.00. For the second quarter, Agree Realty had an EPS of $0.98, compared to year-ago quarter EPS of $0.97. The current stock performance of Agree Realty shows a 52-week-high of $75.71 and a 52-week-low of $58.65. Moreover, at the end of the last trading period, the closing price was at $58.72.

    Wells Fargo initiated coverage on Four Corners Property Trust Inc (NYSE:FCPT) with an Overweight rating. The price target for Four Corners Prop is set to $28.00. For the second quarter, Four Corners Prop had an EPS of $0.42, compared to year-ago quarter EPS of $0.41. The stock has a 52-week-high of $29.30 and a 52-week-low of $22.70. At the end of the last trading period, Four Corners Prop closed at $24.13.

    With an Overweight rating, Wells Fargo initiated coverage on Essential Properties Realty Trust Inc (NYSE:EPRT). The price target seems to have been set at $27.00 for Essential Props Realty. Essential Props Realty earned $0.41 in the second quarter, compared to $0.38 in the year-ago quarter. The stock has a 52-week-high of $26.43 and a 52-week-low of $18.89. At the end of the last trading period, Essential Props Realty closed at $23.48.

    Wells Fargo initiated coverage on VICI Properties Inc (NYSE:VICI) with an Overweight rating. The price target for VICI Props is set to $36.00. In the second quarter, VICI Props showed an EPS of $0.54, compared to $0.48 from the year-ago quarter. The current stock performance of VICI Props shows a 52-week-high of $35.07 and a 52-week-low of $28.49. Moreover, at the end of the last trading period, the closing price was at $30.66.

    With an Underweight rating, Wells Fargo initiated coverage on Spirit Realty Capital Inc (NYSE:SRC). The price target seems to have been set at $36.00 for Spirit Realty Cap. In the second quarter, Spirit Realty Cap showed an EPS of $0.91, compared to $0.90 from the year-ago quarter. The stock has a 52-week-high of $44.65 and a 52-week-low of $34.44. At the end of the last trading period, Spirit Realty Cap closed at $36.67.

    Wells Fargo initiated coverage on EPR Properties (NYSE:EPR) with an Underweight rating. The price target for EPR Props is set to $40.00. For the second quarter, EPR Props had an EPS of $1.28, compared to year-ago quarter EPS of $1.17. At the moment, the stock has a 52-week-high of $47.71 and a 52-week-low of $33.92. EPR Props closed at $42.76 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $ADC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADC
    $ALVO
    $BHF
    $BNL

    CompanyDatePrice TargetRatingAnalyst
    European Wax Center Inc.
    $EWCZ
    2/11/2026$5.80Underweight → Equal-Weight
    Morgan Stanley
    European Wax Center Inc.
    $EWCZ
    2/10/2026$5.80Buy → Hold
    Truist
    Frontier Group Holdings Inc.
    $ULCC
    2/10/2026$6.00Buy → Hold
    Deutsche Bank
    Ultrapar Participacoes S.A. (New)
    $UGP
    2/5/2026$5.40Buy → Neutral
    Goldman
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    Enphase Energy Inc.
    $ENPH
    2/4/2026$41.00Underperform → Market Perform
    BMO Capital Markets
    Enphase Energy Inc.
    $ENPH
    2/4/2026$54.00Sector Perform → Outperform
    RBC Capital Mkts
    Vista Energy S.A.B. de C.V.
    $VIST
    2/4/2026$88.00Buy
    BofA Securities
    More analyst ratings

    $ADC
    $ALVO
    $BHF
    $BNL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    European Wax Center upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded European Wax Center from Underweight to Equal-Weight and set a new price target of $5.80

    2/11/26 7:41:53 AM ET
    $EWCZ
    Other Consumer Services
    Consumer Discretionary

    European Wax Center downgraded by Truist with a new price target

    Truist downgraded European Wax Center from Buy to Hold and set a new price target of $5.80

    2/10/26 9:11:00 AM ET
    $EWCZ
    Other Consumer Services
    Consumer Discretionary

    Frontier Group Holdings downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded Frontier Group Holdings from Buy to Hold and set a new price target of $6.00

    2/10/26 7:47:54 AM ET
    $ULCC
    Air Freight/Delivery Services
    Consumer Discretionary

    $ADC
    $ALVO
    $BHF
    $BNL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-2) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 10:44:05 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-1) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 2:59:28 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-3) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 2:59:28 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADC
    $ALVO
    $BHF
    $BNL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Exec. VP & President Nicholls Timothy S covered exercise/tax liability with 18,887 shares and was granted 52,230 shares, increasing direct ownership by 14% to 276,986 units (SEC Form 4)

    4 - INTERNATIONAL PAPER CO /NEW/ (0000051434) (Issuer)

    2/11/26 3:31:45 PM ET
    $IP
    Paper
    Basic Materials

    Amendment: Exec. VP & President Nicholls Timothy S covered exercise/tax liability with 2,642 shares, decreasing direct ownership by 1% to 243,643 units (SEC Form 4)

    4/A - INTERNATIONAL PAPER CO /NEW/ (0000051434) (Issuer)

    2/11/26 3:29:03 PM ET
    $IP
    Paper
    Basic Materials

    SVP, GC and Corp. Secretary Saab Joseph R. was granted 24,314 shares and covered exercise/tax liability with 7,268 shares, increasing direct ownership by 64% to 43,613 units (SEC Form 4)

    4 - INTERNATIONAL PAPER CO /NEW/ (0000051434) (Issuer)

    2/11/26 3:02:53 PM ET
    $IP
    Paper
    Basic Materials

    $ADC
    $ALVO
    $BHF
    $BNL
    SEC Filings

    View All

    SEC Form 6-K filed by Petroleo Brasileiro S.A. Petrobras

    6-K - PETROBRAS - PETROLEO BRASILEIRO SA (0001119639) (Filer)

    2/12/26 8:04:32 AM ET
    $PBR
    Oil & Gas Production
    Energy

    Organon & Co. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Organon & Co. (0001821825) (Filer)

    2/12/26 7:45:44 AM ET
    $OGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by YPF Sociedad Anonima

    6-K - YPF SOCIEDAD ANONIMA (0000904851) (Filer)

    2/12/26 7:42:58 AM ET
    $YPF
    Integrated oil Companies
    Energy

    $ADC
    $ALVO
    $BHF
    $BNL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    Director Connor Christopher M bought $1,009,250 worth of shares (25,000 units at $40.37) (SEC Form 4)

    4 - INTERNATIONAL PAPER CO /NEW/ (0000051434) (Issuer)

    2/2/26 5:30:10 PM ET
    $IP
    Paper
    Basic Materials

    Chief Executive Officer Silvernail Andrew K bought $1,998,965 worth of shares (50,000 units at $39.98) (SEC Form 4)

    4 - INTERNATIONAL PAPER CO /NEW/ (0000051434) (Issuer)

    1/30/26 4:47:45 PM ET
    $IP
    Paper
    Basic Materials

    $ADC
    $ALVO
    $BHF
    $BNL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Brighthouse Financial Stockholders Approve Merger with Aquarian Capital

    Brighthouse Financial, Inc. ("Brighthouse Financial" or the "company") (NASDAQ:BHF) announced that at a special meeting of stockholders held earlier today, its common stockholders voted to adopt the previously announced definitive merger agreement under which an affiliate of Aquarian Capital LLC will acquire the company in an all-cash transaction valued at approximately $4.1 billion. Under the terms of the merger agreement, Brighthouse Financial's common stockholders will receive $70.00 in cash per share upon consummation of the transaction. "With this approval, we are one step closer to embarking on the next chapter of our company as we continue to deliver on our mission of helping peopl

    2/12/26 8:23:00 AM ET
    $BHF
    Life Insurance
    Finance

    Truist launches secure open banking experience

    New platform empowers consumer and small business clients with more control over financial data and seamless access to trusted fintech tools CHARLOTTE, N.C., Feb. 12, 2026 /PRNewswire/ -- Truist Financial Corporation (NYSE:TFC) today introduced its first open banking integration, connecting first to Mastercard's open finance technology. The API-based platform provides Truist consumer and small business clients with secure, centralized access to their financial data—unlocking transparency, personalization and control across a growing ecosystem of trusted fintech apps.  These c

    2/12/26 8:03:00 AM ET
    $TFC
    Major Banks
    Finance

    Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025

    Full year 2025 revenue of $6.2 billion, down 3% on both an as-reported basis and at constant currency Full year 2025 diluted earnings per share of $0.72 and non-GAAP Adjusted diluted earnings per share of $3.66 Full year 2025 Adjusted EBITDA of $1.91 billion inclusive of $6 million of IPR&D, representing a 30.7% Adjusted EBITDA margin The company expects to deliver approximately $6.2 billion of revenue and approximately $1.9 billion of Adjusted EBITDA for the full year 2026, both measures in-line with full year 2025 performance. Organon (NYSE:OGN) today announced its results for the fourth quarter and full year ended December 31, 2025. "In 2025 we took action that demonstrate

    2/12/26 7:30:00 AM ET
    $OGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADC
    $ALVO
    $BHF
    $BNL
    Financials

    Live finance-specific insights

    View All

    Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025

    Full year 2025 revenue of $6.2 billion, down 3% on both an as-reported basis and at constant currency Full year 2025 diluted earnings per share of $0.72 and non-GAAP Adjusted diluted earnings per share of $3.66 Full year 2025 Adjusted EBITDA of $1.91 billion inclusive of $6 million of IPR&D, representing a 30.7% Adjusted EBITDA margin The company expects to deliver approximately $6.2 billion of revenue and approximately $1.9 billion of Adjusted EBITDA for the full year 2026, both measures in-line with full year 2025 performance. Organon (NYSE:OGN) today announced its results for the fourth quarter and full year ended December 31, 2025. "In 2025 we took action that demonstrate

    2/12/26 7:30:00 AM ET
    $OGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sylvamo Releases Fourth Quarter, Full Year Earnings

    Sylvamo (NYSE:SLVM), the world's paper company, is releasing fourth quarter and full year 2025 earnings. The company will host an audio webcast at 10 a.m. EST at investors.sylvamo.com. Management Summary from Chief Executive Officer John Sims As Sylvamo's CEO, my vision is that Sylvamo will be legendary for the way we relentlessly pursue and achieve world-class excellence in all that we do. This will create substantial and lasting value for our employees, customers and shareowners and will enable us to be the employer, supplier and investment of choice. I am committed to allocating capital wisely to create long-term value, communicating transparently, upholding our values and driving

    2/12/26 7:00:00 AM ET
    $IP
    $SLVM
    Paper
    Basic Materials

    FCPT Announces Fourth Quarter 2025 Financial and Operating Results

    Four Corners Property Trust, Inc. (("FCPT" or the "Company", NYSE:FCPT) today announced financial results for the three and twelve months ended December 31, 2025. Management Comments "FCPT delivered another strong year in 2025, achieved by raising capital efficiently and by deploying that capital into a series of high value new investments. We invested a near record $318 million across 105 properties located in strong retail corridors and leased to a set of nationally branded operators. We achieved these results while never wavering from our commitment to using an insights driven scoring system and to maintaining a steadfast set of pricing objectives," said CEO Bill Lenehan. "We funded

    2/11/26 4:05:00 PM ET
    $FCPT
    Real Estate Investment Trusts
    Real Estate

    $ADC
    $ALVO
    $BHF
    $BNL
    Leadership Updates

    Live Leadership Updates

    View All

    Frontier Group Holdings, Inc. Announces New Board Member

    DENVER, Feb. 9, 2026 /PRNewswire/ -- Frontier Group Holdings, Inc. ((ULCC), parent company of Frontier Airlines, Inc., today announced the appointment of Anthony Salcido to the company's Board of Directors. "We are very pleased to have Mr. Salcido join the Frontier Board of Directors," said William A. Franke, chairman of Frontier Group Holdings, Inc. "His deep experience in corporate financial leadership and other key areas of financial discipline will be of tremendous benefit to our organization." Mr. Salcido served as the Chief Accounting Officer of Toyota Motors North Ameri

    2/9/26 4:05:00 PM ET
    $ULCC
    Air Freight/Delivery Services
    Consumer Discretionary

    Resolutions Adopted by the Extraordinary Shareholders' Meeting of February 5th 2026

    BOGOTA, Colombia, Feb. 5, 2026 /PRNewswire/ -- Ecopetrol S.A. ((BVC: ECOPETROL, NYSE:EC) ("Ecopetrol" or the "Company") announces that, during the Extraordinary Shareholders' Meeting held on February 5, 2026, at 8:40 a.m., duly convened in accordance with the legal and statutory requirements applicable to the Company, the shareholders approved the election of the members of Ecopetrol's Board of Directors for the remainder of the 2025–2029 term, pursuant to Article 187, paragraph 4, of the Colombian Commercial Code. The shareholders also addressed the remaining items on the agenda, as detailed below:

    2/5/26 5:52:00 PM ET
    $EC
    Oil & Gas Production
    Energy

    Shareowners Elect Five Directors at the 2026 New Jersey Resources Annual Meeting

    At the 2026 Annual Meeting of New Jersey Resources (NYSE:NJR) held virtually today, shareowners elected Jane M. Kenny, Amy B. Mansue, Sharon C. Taylor, Stephen D. Westhoven and Willian T. Yardley to NJR's Board of Directors each for a three-year term that will expire in 2029. "We have an exceptional group of directors whose expertise and vision drives our growth strategy," said Steve Westhoven, President and CEO of New Jersey Resources. "I appreciate our shareowners' support for our directors, including me, and I look forward to working with Jane, Amy, Sharon and Bill and the rest of the Board to honor that confidence by continuing to deliver long-term value." Also at the Annual Meeting

    1/21/26 10:20:00 AM ET
    $NJR
    Oil/Gas Transmission
    Utilities

    $ADC
    $ALVO
    $BHF
    $BNL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Seelos Therapeutics Inc.

    SC 13G/A - SEELOS THERAPEUTICS, INC. (0001017491) (Subject)

    12/4/24 1:29:12 PM ET
    $SEEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Five9 Inc.

    SC 13G - Five9, Inc. (0001288847) (Subject)

    11/21/24 6:17:26 AM ET
    $FIVN
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Seelos Therapeutics Inc.

    SC 13G/A - SEELOS THERAPEUTICS, INC. (0001017491) (Subject)

    11/14/24 7:32:44 PM ET
    $SEEL
    Biotechnology: Pharmaceutical Preparations
    Health Care